Lonza Biologics plc; est. no. 1209

Lonza Biologics plc - 228 Bath Road, Slough, Berkshire, SL1 4DY, United Kingdom; with facilities in Slough SL1 4DY, Berkshire, U.K, and Portsmouth, NH; subsidiary of (majority owned by) Alusuise-Lonza Group.; includes former parts of Celltech, which merged with Chiroscience Group plc in June 1999 and acquired Medeva plc later in 1999, forming Celltech Medeva, later acquired by Alusuise-Lonza.

Related product monographs:

1. Antithrombin III, rDNA -- Parent
2. Anthrax Mab, rDNA/Elusys -- Manuf. ; Tech.
3. B-cell-activating factor Mab, rDNA -- Manuf.
4. CD20 Mab, rDNA -- Manuf. ; Tech.
5. CD20 Mab, rDNA conc. -- Manuf.
6. CD20 Mab, human, rDNA -- Manuf.
7. CD33 immunotoxin, rDNA -- Tech.
8. CD52 Mab, rDNA -- Tech.
9. Complement C5 Mab, rDNA -- Manuf
10. CTLA4-Ig, rDNA -- Manuf.
11. CTLA-4 Mab, rDNA/BMS -- Manuf. ; Former inv.
12. EGF receptor Mab, chimeric, rDNA -- Manuf. ; Tech.
13. EPO, rDNA/TKT -- Manuf. ; Tech.
14. Galactosidase, alfa, rDNA -- Parent
15. HER2 receptor Mab, rDNA -- Tech.
16. Insulin-like Growth Factor-1, rDNA/Tercica -- Parent
17. Interleukin-2/diphtheria toxin, rDNA -- Parent
18. Interleukin-2 receptor Mab, rDNA/Novartis -- Tech.
19. Interleukin-2 receptor Mab, rDNA/Roche -- Manuf. ; Tech.
20. Protein C, activated, rDNA -- Manuf. ; Tech.
21. RSV Mab, rDNA -- Tech.
22. TNF Mab, rDNA/J&J -- Tech.
23. TNF Mab Fab', rDNA, PEG- -- Manuf
24. VEGF Mab, rDNA -- Manuf.
25. TAG-72 Mab, conc. -- Manuf. ; R&D ; Tech. ; Former
26. TAG-72 Mab–In111 radioconj./Cytogen -- Manuf. other
27. Dendritic Cell Vaccine, Personalized/DCVax -- Patent dispute
28. Staphylococcus vaccine (rDNA) -- Parent
29. Liprotamase, rDNA -- Manuf.
30. Skin, Cultured/Ortec -- Parent
31. Interferon, leukocyte/HemispheRx -- Manuf. other ; Tech.
32. Hirudin, synthetic -- Former

Location - Slough Portsmouth NH Berkshire SL1 4DY UK For USA

Further information:
Description, ordering information, etc.
Order/Inquiry
Products Database

Copyright ©2020. Biotechnology Information Institute